Technical Analysis for FHTX - Foghorn Therapeutics Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 5.93 | 0.34% | 0.02 |
FHTX closed up 0.34 percent on Monday, March 18, 2024, on 43 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
200 DMA Resistance | Bearish | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
200 DMA Resistance | Bearish | 0.34% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.34% | |
Spinning Top | Other | 0.34% | |
Stochastic Reached Oversold | Weakness | 0.34% | |
Wide Bands | Range Expansion | 0.34% |
Alert | Time |
---|---|
Possible Inside Day | about 12 hours ago |
200 DMA Resistance | about 16 hours ago |
Up 5% | about 16 hours ago |
Up 3% | about 16 hours ago |
Down 2 % | about 16 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/08/2023
Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control™ platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology and expects to file an IND for its first program later this year.
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Biology Medication
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Biology Medication
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 9.96 |
52 Week Low | 2.7 |
Average Volume | 187,163 |
200-Day Moving Average | 6.08 |
50-Day Moving Average | 5.40 |
20-Day Moving Average | 6.68 |
10-Day Moving Average | 6.46 |
Average True Range | 0.73 |
RSI (14) | 46.81 |
ADX | 26.54 |
+DI | 19.41 |
-DI | 18.24 |
Chandelier Exit (Long, 3 ATRs) | 6.26 |
Chandelier Exit (Short, 3 ATRs) | 7.96 |
Upper Bollinger Bands | 7.99 |
Lower Bollinger Band | 5.37 |
Percent B (%b) | 0.22 |
BandWidth | 39.24 |
MACD Line | 0.19 |
MACD Signal Line | 0.39 |
MACD Histogram | -0.2079 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 6.51 | ||||
Resistance 3 (R3) | 6.54 | 6.36 | 6.42 | ||
Resistance 2 (R2) | 6.36 | 6.21 | 6.35 | 6.38 | |
Resistance 1 (R1) | 6.15 | 6.12 | 6.06 | 6.12 | 6.35 |
Pivot Point | 5.97 | 5.97 | 5.93 | 5.96 | 5.97 |
Support 1 (S1) | 5.76 | 5.82 | 5.67 | 5.74 | 5.51 |
Support 2 (S2) | 5.58 | 5.73 | 5.57 | 5.48 | |
Support 3 (S3) | 5.37 | 5.58 | 5.44 | ||
Support 4 (S4) | 5.35 |